CryoXtract is excited to participate in this year's Global Engage Microbiome R&D and Business Collaboration Forum in San Diego. The event on September 10th and 11th brings together over 200 industry leaders for engaging panel discussions, presentations and exhibition. Key topics include highlights of new microbiome research, discussions of venture and other capital investment in the field, and more.
The National Comprehensive Cancer Network hosted its policy summit on June 8, 2015 in Washington, D.C. Discussions centering around the theme “Emerging Issues in Tissue Allocation” addressed increasing concern in the oncology research community about the proper acquisition and management of highly valuable, and often especially fragile, biospecimen resources.
The annual conference of the American Society for Mass Spectrometry, held during the first week in June, highlighted new workflow solutions for clinical research. During the event, CryoXtract presented a poster on recent research with GlaxoSmithKline focused on the ex vivo stabilization of small molecules and peptides using frozen aliquotting in bioanalytical workflows.
Last week, CryoXtract presented two posters at the 2015 annual meeting of the International Society for Biological and Environmental Repositories (ISBER) in Phoenix, AZ. The meeting’s theme, “Connecting Biobank Communities through Innovations in Global Health, Research and Environmental Preservation,” featured symposia on topics ranging from biobanking informatics and infrastructure to community engagement.
At this week’s SLAS conference held in Washington, D.C., CryoXtract offered “Ex vivo Stabilization of Small Molecule Compounds and Peptides in EDTA Plasma for LC-MS/MS Analysis Using Frozen Aliquotting,” an application note on its CXT 750 Frozen Sample Aliquotter and its potential for maintaining small molecule and peptide stability. This research, generated in collaboration with GlaxoSmithKline, demonstrates the benefits of the frozen aliquotting solution for applications in analytical chemistry and drug metabolism pharmacokinetics (DMPK) groups, and is a potentially significant development for improving drug stability in serum and plasma samples.
The research demonstrates the benefits of the frozen aliquotting solution as a valuable tool for compound stabilization and bioanalysis. In addition to improving clarity for bioanalysis by lessening the impact of ex vivo degradation and improving the efficiency of frozen sample utilization, frozen aliquotting could also potentially reduce the time required for assay development and validation and greatly simplify sample collection, processing, and handling protocols for bioanalytical efforts. These measures are required to keep the drug molecules sufficiently stable to permit meaningful analysis by mass spectrometry.
CryoXtract will be participating in the annual conference of the Society for Laboratory Automation and Screening (SLAS) held in Washington, DC this week. SLAS represents an international community of life science researchers and development professionals. The annual conference and exhibition highlights topics such as bioanalytical techniques, automation, and drug target strategies, among others. Outcomes of the event frequently become a global reference for automation advances in life sciences and drug discovery.
The microbiome as a source for solutions to the increasingly prevalent issue of antibiotic resistance is an idea gaining attention in the scientific community. This week’s Microbiome Forum: Asia addresses numerous topics in the field of microbiome research including the critical issue of antibiotic resistance.
A recent post on Forbes.com (found here) reviews some of the headlines on the topic and dramatic projections about the rising number of deaths due to antimicrobial resistance (AMR) between now and 2050. Also mentioned is a report by the UK’s Wellcome Trust. The report projects that antibiotic resistance could cost up to $100 trillion and reduce Gross Domestic Product by 2-3.5%.
The annual conference of the European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB), held in Leipzig last month set forth a theme entitled, “A Chorale Symphony of Science, Technology and Human Rights,” and provided a lineup of presentations that discussed new initiatives and technology advances in biobanking.